menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Almac Opens $83.9M Commercial Manufacturing Facility In Craigavon

    CONTRACTPHARMA

    Almac Invests in Instrumentation at Spectroscopy Labs

    CONTRACTPHARMA

    Almac announces key partnership with Future Medicines Institute

    PRESS RELEASE

    Almac’s Singapore facility secures GMP Certification

    PRESS RELEASE

    Almac Pharma Services Announces Recruitment Event At HQ

    PRESS RELEASE

    Almac Chemist Recognised As "Future Leader" At CPHI Awards

    PRESS RELEASE

    Almac Group Announces £11m Investment For Global Services

    PRESS RELEASE

    Almac Pharma Services Appoints New VP Finance

    PRESS RELEASE

    Arran Chemical Company celebrates 40 successful years in business

    PRESS RELEASE

    Almac Group North American Headquarters Expansion PV, USA

    PHARMATECH

    Almac Services Joins European Paediatric Formulation Initiative

    PRESS RELEASE

    Almac Announces Investment in Singapore to Enhance Cold Chain Facility

    PRESS RELEASE

    Almac Completes FDA Inspection at Charnwood, UK Facilities

    CONTRACT PHARMA

    Almac Group’s Renewable Energy Power Purchase Agreement Goes Live

    PRESS RELEASE

    Almac Pharma Services Supports Rapid Launch of BioLineRx’s APHEXDA motixafortide

    PRESS RELEASE

    Almac Pharma Services Appoints New VP Business Development

    PRESS RELEASE

    Almac Discovery nominates ALM-401 First Class Bispecific Next Generation ADC

    PRESS RELEASE

    Almac’s 2023 revenue bump; France to invest in easing greenhouse gas impact

    ENDPTS

    Almac Group announces record revenue figure resulting from another year growth

    PRESS RELEASE

    Almac Pharma Services Supports Industry Consortium to Address Titanium Dioxide

    PRESS RELEASE

    Amicus Inc & Almac Pharma Services Mark 15-year Strategic Partnership

    PRESS RELEASE

    Almac Clinical celebrates Grace Science in dosing first NGLY1 deficient patien

    PRESS RELEASE

    Almac Pharma Appoints New Director of Manufacturing Science & Technology

    PRESS RELEASE

    Almac Group announces support of ESG category at this year’s Belfast

    PRESS RELEASE

    Tonix Pharmaceuticals Selects 2 CMOs to Support Tonmya in the U.S.

    CONTRACT PHARMA

    Almac Sciences awarded Life Sciences Innovative Manufacturing Fund Grant

    PRESS RELEASE

    Almac Group Awarded six 2024 CDMO Leadership Awards

    PRESS RELEASE

    Almac continues its expansion with completion of 2 facilities

    FIERCE PHARMA

    Almac Pharma Services Renew HPRA GMP Certification for European Facility

    PRESS RELEASE

    Almac Group signs virtual power purchase agreement (VPPA) for renewable energy

    PRESS RELEASE

    Almac Sciences extends select AZyme offering to therapeutic oligonucleotide

    PRESS RELEASE

    Almac Launches Manufacturing and Development Recruitment Drive

    PRESS RELEASE

    Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus

    CONTRACT PHARMA

    Almac Group Global Workforce Hits 7,000 Employees

    CONTRACT PHARMA

    Almac Group joins Employers for Carers to further support working carers

    PRESS RELEASE

    Almac Diagnostic updates clara? report with new content for cancer research

    PRESS RELEASE

    Almac Pharma Services Hosts Recruitment Open Day in Loughborough

    PRESS RELEASE

    Almac Group Hosts Recruitment Open Day in the North West as 20 new jobs

    PRESS RELEASE

    Almac Sciences & University College Dublin BROADEN Flow Chemistry Collaboration

    PRESS RELEASE

    Almac Announces Launch of IXRS®3 Partnership Network

    PRESS RELEASE

    Almac Appoints Global Energy Manager as part of ongoing commitment

    PRESS RELEASE

    Almac Group Receives Product Approval from FDA, MHRA and Health Canada

    CONTRACTPHARMA

    Almac Introduces New Cryogenic Service Solution

    CONTRACTPHARMA

    Almac commits to $65M expansion for its Pennsylvania HQ amid wider investments

    ENDPTS

    Almac Invests $65M to Expand North American HQ

    THEPHARMALETTER

    Almac Group Unveils $250M Global Expansion Plans

    CONTRACTPHARMA

    Almac Invests in NMR Technology to Enhance Analytical Services

    CONTRACTPHARMA

    Almac Sciences, IMR Collaborate to Enhance Flow Chemistry Expertise

    CONTRACTPHARMA

    Exploring ICP-MS expertise at Almac

    CONTRACTPHARMA

    Almac, PILA PHARMA Enter API Manufacturing Pact

    CONTRACT PHARMA

    Almac Expands Crystallization Capabilities

    CONTRACTPHARMA

    Almac Sciences Invests in Continuous Flow Chemistry Equipment

    CONTRACTPHARMA

    Almac Sciences to Invest in Continuous Flow Chemistry Equipment New R&D Center

    PHARMTECH

    Almac Group Completes $7M R&D Center

    CONTRATCTPHARMA

    Almac Invests in Expanding Global Biologics Testing Solutions

    PHARMTECH

    Almac Invests in Expanding Global Biologics Testing Solutions

    PHARMTECH

    Almac Sciences Secures Support from Invest NI

    CONTRACTPHARMA

    Almac secures grant to scale COVID-19 drug production

    OUTSOURCING-PHARMA

    Almac appoints Dan Bayston VP of Small Molecule API

    MANUFACTURING CHEMIST

    Almac launches clinical site temperature data tool

    OUTSOURCING-PHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.